blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2288594

EP2288594 - IMIDAZOLIDINE DERIVATIVES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.05.2015
Database last updated on 11.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK		published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
F. Hoffmann-La Roche AG
Grenzacherstraße 124
4070 Basel / CH
[2014/27]
Former [2011/09]For all designated states
F. Hoffmann-La Roche AG
Grenzacherstrasse 124
4070 Basel / CH
Inventor(s)01 / DEHMLOW, Henrietta
Albert-Richter-Strasse 2
79540 Loerrach / DE
02 / OBST SANDER, Ulrike
Therwilerstrasse 41
CH-4153 Reinach BL / CH
03 / SCHULZ-GASCH, Tanja
Baselweg 7
4417 Ziefen / CH
04 / WRIGHT, Matthew
Pfeffingerstrasse 16
CH-4053 Basel / CH
 [2011/19]
Former [2011/09]01 / DEHMLOW, Henrietta
Albert-Richter-Strasse 2
79540 Loerrach / DE
02 / OBST SANDER, Ulrike
Therwilerstrasse 41
CH-4153 Reinach BL / CH
03 / SCHULZ-GASCH, Tanja
Aurorastrasse 32
CH-4410 Liestal / CH
04 / WRIGHT, Matthew
Pfeffingerstrasse 16
CH-4053 Basel / CH
Representative(s)Pomeranc, Didier
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
[2014/27]
Former [2011/09]Pomeranc, Didier
F. Hoffmann-La Roche AG Patent Department Grenzacherstrasse 124
4070 Basel / CH
Application number, filing date09761672.608.06.2009
[2011/09]
WO2009EP56986
Priority number, dateEP2008015807511.06.2008         Original published format: EP 08158075
[2011/09]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009150109
Date:17.12.2009
Language:EN
[2009/51]
Type: A1 Application with search report 
No.:EP2288594
Date:02.03.2011
Language:EN
The application published by WIPO in one of the EPO official languages on 17.12.2009 takes the place of the publication of the European patent application.
[2011/09]
Type: B1 Patent specification 
No.:EP2288594
Date:02.07.2014
Language:EN
[2014/27]
Search report(s)International search report - published on:EP17.12.2009
ClassificationIPC:C07D211/96, C07D233/38, C07D241/04, C07D241/08, C07D401/10, C07D413/12, A61K31/4166, A61K31/451, A61K31/495, A61P3/06
[2011/09]
CPC:
C07D233/38 (EP,US); A61P1/04 (EP); A61P1/16 (EP);
A61P1/18 (EP); A61P17/00 (EP); A61P17/06 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P29/00 (EP);
A61P3/00 (EP); A61P3/06 (EP); A61P3/10 (EP);
A61P31/04 (EP); A61P31/18 (EP); A61P35/00 (EP);
A61P43/00 (EP); A61P9/10 (EP); C07D211/96 (EP,US);
C07D241/04 (EP,US); C07D241/08 (EP,US); C07D401/10 (EP,US);
C07D413/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2011/09]
TitleGerman:IMIDAZOLINDERIVATE[2011/09]
English:IMIDAZOLIDINE DERIVATIVES[2011/09]
French:DÉRIVÉS D IMIDAZOLIDINE[2011/09]
Entry into regional phase11.01.2011National basic fee paid 
11.01.2011Designation fee(s) paid 
11.01.2011Examination fee paid 
Examination procedure11.01.2011Examination requested  [2011/09]
18.02.2011Amendment by applicant (claims and/or description)
25.07.2012Despatch of a communication from the examining division (Time limit: M04)
06.11.2012Reply to a communication from the examining division
20.02.2014Communication of intention to grant the patent
22.05.2014Fee for grant paid
22.05.2014Fee for publishing/printing paid
22.05.2014Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.07.2012
Opposition(s)07.04.2015No opposition filed within time limit [2015/24]
Fees paidRenewal fee
07.06.2011Renewal fee patent year 03
31.03.2012Renewal fee patent year 04
31.03.2013Renewal fee patent year 05
31.03.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.06.2009
AT02.07.2014
BE02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MK02.07.2014
MT02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
[2018/30]
Former [2017/40]HU08.06.2009
AT02.07.2014
BE02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MT02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2017/03]AT02.07.2014
BE02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
MT02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2016/32]AT02.07.2014
BE02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2016/09]AT02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
MC02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2015/50]AT02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SI02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2015/23]AT02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
EE02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
SK02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2015/22]AT02.07.2014
CY02.07.2014
CZ02.07.2014
DK02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
NL02.07.2014
PL02.07.2014
RO02.07.2014
SE02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2015/12]AT02.07.2014
CY02.07.2014
CZ02.07.2014
FI02.07.2014
HR02.07.2014
LT02.07.2014
LV02.07.2014
NL02.07.2014
PL02.07.2014
SE02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
IS02.11.2014
PT03.11.2014
Former [2015/11]CY02.07.2014
CZ02.07.2014
FI02.07.2014
LT02.07.2014
PL02.07.2014
SE02.07.2014
BG02.10.2014
NO02.10.2014
GR03.10.2014
PT03.11.2014
Former [2015/10]CZ02.07.2014
FI02.07.2014
LT02.07.2014
SE02.07.2014
BG02.10.2014
NO02.10.2014
Former [2015/09]FI02.07.2014
LT02.07.2014
SE02.07.2014
Former [2015/08]LT02.07.2014
Cited inInternational search[A]US2006040999  (ALI AMJAD [US], et al) [A] 1-30 * examples 376,377 * * claims 1,18-20 *;
 [A]US2006074103  (CORTE JAMES R [US], et al) [A] 1* page 65 - page 66; table 1 *;
 [A]  - BENNETT D J ET AL, "An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, (20060101), vol. 16, no. 12, ISSN 1354-3776, pages 1673 - 1699, XP002500308 [A] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1517/13543776.16.12.1673
 [A]  - BENNETT D J ET AL, "Design, structure activity relationships and X-ray co-crystallography of non-steroidal LXR agonists", CURRENT MEDICINAL CHEMISTRY 200801 NL, (200801), vol. 15, no. 2, ISSN 0929-8673, pages 195 - 209, XP002540630 [A] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.2174/092986708783330584
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.